A team from the University’s School of Biosciences examined the differences between Ebolaviruses that cause severe disease in humans and the Reston virus that does … Read more
Tag: michaelis
Research offers potential new treatment for children’s cancer
The team, including Professor Martin Michaelis and Dr Mark Wass at Kent’s School of Biosciences, found that flubendazole – a drug used against parasitic worms … Read more
Cancer expert discovers novel pharmacological action of a candidate anti-cancer drug
Enzastaurin is a compound that is under clinical investigation as anti-cancer drug. It has been developed as inhibitor of protein kinase beta, a serine/threonine kinase … Read more